Cargando…
Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted
OBJECTIVE: To assess whether new pharmaceutical products approved by the United States Food and Drug Administration (FDA) in 2011 and 2012 were registered, commercialized and sold at affordable prices in the Latin American countries where they were tested. METHODS: We obtained a list of new molecula...
Autores principales: | Homedes, Núria, Ugalde, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645434/ https://www.ncbi.nlm.nih.gov/pubmed/26600609 http://dx.doi.org/10.2471/BLT.14.151290 |
Ejemplares similares
-
Health and Ethical Consequences of Outsourcing Pivotal Clinical Trials to Latin America: A Cross-Sectional, Descriptive Study
por: Homedes, Núria, et al.
Publicado: (2016) -
Human resources: the Cinderella of health sector reform in Latin America
por: Homedes, Núria, et al.
Publicado: (2005) -
Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America
por: Moye-Holz, Daniela, et al.
Publicado: (2021) -
Twenty-Five Years of Convoluted Health Reforms in Mexico
por: Homedes, Núria, et al.
Publicado: (2009) -
Mexican Pharmacies and Antibiotic Consumption at the US-Mexico Border
por: Homedes, Núria, et al.
Publicado: (2012)